The Pharma world is seeing a big opportunity in GLP-1s – the new innovative fast emerging drugs for diabetes & obesity. Kiran ...

Novo Nordisk’s semaglutide product to lose patent protection in China next year, according to L.E.K. Consulting.

Legal battle over semaglutide between Novo Nordisk and Indian drugmakers will set precedent for future opportunities and ...

Dr Reddy's Laboratories had received the manufacturing licence for semaglutide in December 2024 and it began production in ...

Doctors from around the world recently teamed up to study a new pill that could help people with type 2 diabetes manage their ...

A warning from the medicines watchdog that weight-loss drugs such as Ozempic are increasingly becoming available through ...

Shares of firms like IndiGo, Tata Motors, BPCL, Vodafone Idea, BPCL, Nykaa, and others will be in focus on Monday's trade ...

Several companies are in the spotlight. Indigo's damp-leased aircraft extension aids operations. Tata Motors' sales declined, ...